US Stock MarketDetailed Quotes

Advanced Biomed (ADVB)

Watchlist
  • 0.2960
  • -0.0207-6.54%
Close Jan 16 16:00 ET
6.41MMarket Cap-1.90P/E (TTM)

Advanced Biomed (ADVB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.75%523.91K
18.86%3.02M
72.09%1.21M
2.32%762.74K
-19.28%525.73K
18.12%520.03K
-17.25%2.54M
-30.86%704.61K
-5.67%745.41K
-23.66%651.3K
Selling and administrative expenses
-16.21%260.6K
40.08%1.77M
396.58%878.99K
8.41%438.77K
-64.39%155.21K
27.41%311.03K
-4.61%1.26M
-34.44%177.01K
-26.87%404.74K
68.58%435.9K
-General and administrative expense
-16.21%260.6K
40.08%1.77M
396.58%878.99K
8.41%438.77K
-64.39%155.21K
27.41%311.03K
-4.61%1.26M
-34.44%177.01K
-26.87%404.74K
68.58%435.9K
Research and development costs
29.88%235.99K
3.36%909.77K
12.01%234.23K
-20.11%250.46K
29.19%243.38K
7.40%181.7K
-36.36%880.19K
-57.16%209.11K
50.60%313.51K
-66.96%188.39K
Depreciation amortization depletion
0.10%27.32K
-13.96%343.83K
-68.81%99.33K
170.60%73.51K
370.71%127.14K
1.33%27.29K
9.41%399.6K
22.02%318.49K
-5.14%27.17K
10.68%27.01K
-Depreciation and amortization
0.10%27.32K
-13.96%343.83K
-68.81%99.33K
170.60%73.51K
370.71%127.14K
1.33%27.29K
9.41%399.6K
22.02%318.49K
-5.14%27.17K
10.68%27.01K
Operating profit
-0.75%-523.91K
-18.86%-3.02M
-72.09%-1.21M
-2.32%-762.74K
19.28%-525.73K
-18.12%-520.03K
17.25%-2.54M
30.86%-704.61K
5.67%-745.41K
23.66%-651.3K
Net non-operating interest income expense
4,380.00%448
-53.43%24.92K
-71.53%9.51K
0
-22.78%15.42K
-28.57%10
149.95%53.5K
57.01%33.41K
119.08%104
8,813.39%19.97K
Non-operating interest income
4,380.00%448
-53.43%24.92K
-71.53%9.51K
--0
-22.78%15.42K
-28.57%10
149.95%53.5K
57.01%33.41K
119.08%104
8,813.39%19.97K
Other net income (expense)
-46.33%136.57K
10.66%-262.85K
462.86%501.42K
-99.77%-621.14K
-181.81%-397.59K
176.85%254.44K
56.92%-294.2K
79.76%-138.18K
-214.03%-310.92K
3.93%485.99K
Gain on sale of security
-45.95%136.26K
20.66%-233.81K
404.50%501.56K
-118.24%-621.98K
----
176.00%252.1K
42.40%-294.69K
---164.72K
---284.99K
----
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
-Gain on sale of business
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-87.06%303
-6,075.31%-29.04K
-100.55%-145
103.24%841
-181.81%-397.59K
287.58%2.34K
102.30%486
227.31%26.53K
-109.51%-25.93K
3.93%485.99K
Income before tax
-45.68%-386.9K
-17.13%-3.26M
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.9K
65.57%-265.58K
25.46%-2.78M
51.84%-809.39K
-103.86%-1.06M
62.29%-145.35K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-45.68%-386.9K
-17.13%-3.26M
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.9K
65.57%-265.58K
25.46%-2.78M
51.84%-809.39K
-103.86%-1.06M
62.29%-145.35K
Net income continuous Operations
-45.68%-386.9K
-17.13%-3.26M
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.9K
65.57%-265.58K
25.46%-2.78M
51.84%-809.39K
-103.86%-1.06M
62.29%-145.35K
Minority interest income
Net income attributable to the parent company
-45.68%-386.9K
-17.13%-3.26M
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.9K
65.57%-265.58K
25.46%-2.78M
51.84%-809.39K
-103.86%-1.06M
62.29%-145.35K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-45.68%-386.9K
-17.13%-3.26M
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.9K
65.57%-265.58K
25.46%-2.78M
51.84%-809.39K
-103.86%-1.06M
62.29%-145.35K
Basic earnings per share
-62.96%-0.02
-24.44%-0.16
19.79%-0.03
-43.42%-0.07
-524.70%-0.042
65.57%-0.0123
25.46%-0.1286
51.84%-0.0374
-1,077.54%-0.0488
-117.84%-0.0067
Diluted earnings per share
-62.96%-0.02
-24.44%-0.16
19.79%-0.03
-43.42%-0.07
-524.70%-0.042
65.57%-0.0123
25.46%-0.1286
51.84%-0.0374
-1,077.54%-0.0488
-117.84%-0.0067
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.75%523.91K18.86%3.02M72.09%1.21M2.32%762.74K-19.28%525.73K18.12%520.03K-17.25%2.54M-30.86%704.61K-5.67%745.41K-23.66%651.3K
Selling and administrative expenses -16.21%260.6K40.08%1.77M396.58%878.99K8.41%438.77K-64.39%155.21K27.41%311.03K-4.61%1.26M-34.44%177.01K-26.87%404.74K68.58%435.9K
-General and administrative expense -16.21%260.6K40.08%1.77M396.58%878.99K8.41%438.77K-64.39%155.21K27.41%311.03K-4.61%1.26M-34.44%177.01K-26.87%404.74K68.58%435.9K
Research and development costs 29.88%235.99K3.36%909.77K12.01%234.23K-20.11%250.46K29.19%243.38K7.40%181.7K-36.36%880.19K-57.16%209.11K50.60%313.51K-66.96%188.39K
Depreciation amortization depletion 0.10%27.32K-13.96%343.83K-68.81%99.33K170.60%73.51K370.71%127.14K1.33%27.29K9.41%399.6K22.02%318.49K-5.14%27.17K10.68%27.01K
-Depreciation and amortization 0.10%27.32K-13.96%343.83K-68.81%99.33K170.60%73.51K370.71%127.14K1.33%27.29K9.41%399.6K22.02%318.49K-5.14%27.17K10.68%27.01K
Operating profit -0.75%-523.91K-18.86%-3.02M-72.09%-1.21M-2.32%-762.74K19.28%-525.73K-18.12%-520.03K17.25%-2.54M30.86%-704.61K5.67%-745.41K23.66%-651.3K
Net non-operating interest income expense 4,380.00%448-53.43%24.92K-71.53%9.51K0-22.78%15.42K-28.57%10149.95%53.5K57.01%33.41K119.08%1048,813.39%19.97K
Non-operating interest income 4,380.00%448-53.43%24.92K-71.53%9.51K--0-22.78%15.42K-28.57%10149.95%53.5K57.01%33.41K119.08%1048,813.39%19.97K
Other net income (expense) -46.33%136.57K10.66%-262.85K462.86%501.42K-99.77%-621.14K-181.81%-397.59K176.85%254.44K56.92%-294.2K79.76%-138.18K-214.03%-310.92K3.93%485.99K
Gain on sale of security -45.95%136.26K20.66%-233.81K404.50%501.56K-118.24%-621.98K----176.00%252.1K42.40%-294.69K---164.72K---284.99K----
Special income (charges) --------------------------0------------
-Gain on sale of business --------------------------0------------
Other non- operating income (expenses) -87.06%303-6,075.31%-29.04K-100.55%-145103.24%841-181.81%-397.59K287.58%2.34K102.30%486227.31%26.53K-109.51%-25.93K3.93%485.99K
Income before tax -45.68%-386.9K-17.13%-3.26M13.32%-701.61K-31.02%-1.38M-524.65%-907.9K65.57%-265.58K25.46%-2.78M51.84%-809.39K-103.86%-1.06M62.29%-145.35K
Income tax 0000000000
Net income -45.68%-386.9K-17.13%-3.26M13.32%-701.61K-31.02%-1.38M-524.65%-907.9K65.57%-265.58K25.46%-2.78M51.84%-809.39K-103.86%-1.06M62.29%-145.35K
Net income continuous Operations -45.68%-386.9K-17.13%-3.26M13.32%-701.61K-31.02%-1.38M-524.65%-907.9K65.57%-265.58K25.46%-2.78M51.84%-809.39K-103.86%-1.06M62.29%-145.35K
Minority interest income
Net income attributable to the parent company -45.68%-386.9K-17.13%-3.26M13.32%-701.61K-31.02%-1.38M-524.65%-907.9K65.57%-265.58K25.46%-2.78M51.84%-809.39K-103.86%-1.06M62.29%-145.35K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -45.68%-386.9K-17.13%-3.26M13.32%-701.61K-31.02%-1.38M-524.65%-907.9K65.57%-265.58K25.46%-2.78M51.84%-809.39K-103.86%-1.06M62.29%-145.35K
Basic earnings per share -62.96%-0.02-24.44%-0.1619.79%-0.03-43.42%-0.07-524.70%-0.04265.57%-0.012325.46%-0.128651.84%-0.0374-1,077.54%-0.0488-117.84%-0.0067
Diluted earnings per share -62.96%-0.02-24.44%-0.1619.79%-0.03-43.42%-0.07-524.70%-0.04265.57%-0.012325.46%-0.128651.84%-0.0374-1,077.54%-0.0488-117.84%-0.0067
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More